Download PDF Flyer
eISBN: 978-1-60805-107-6, 2010 ISBN: 978-1-60805-358-2
Indexed in: Book Citation Index, Science Edition, Scopus, EBSCO.
Hypercalcemia is a relatively common disorder, which requires specific treatment in order to control symptoms and prevent the development of organ damage. Primary hyperparathyroidism and malignancy are responsible for most cases of hypercalcemia, and treatment has therefore been focused towards these two areas.
The aim of this book is to present updated knowledge on hypercalcemia, its association with renal disorders, and benign and malignant diseases, diagnostic methodologies, as well as surgical and medical treatment. Insights into the etiology, pathogenesis and pathophysiology of hypercalcemia are included along with details on biochemical findings and ways to monitor complications and therapy. Suggestions on current imaging techniques and surgical treatment of hypercalcemia, are also presented. The book presents an overview on the pharmacology of anti-hypercalcemic drugs, also providing information on new drugs and future perspectives.
The book will serve as a comprehensive reference source for oncologists, nephrologists, endocrinologists, clinicians, biochemists and pharmacologists, as well those involved in hypercalcemia management and research.
John G. Delinassios
Director International Institute of Anticancer Research Athens, Greece.